inExpose

Studies addressing the potential risks associated with electronic cigarette (e-cig) usage are urgently needed, given their rising use and popularity, especially in youth.  Coordinated efforts are [...]

emka & SCIREQ offer a unique perspective into the preclinical study of heart and lung diseases, allowing for novel insights into cardiopulmonary diseases such as heart failure, arrhythmia, [...]

Many novel inhaled compounds and drugs require dry powder delivery and preclinical testing to assess efficacy and safety. The inExpose is an inhalation exposure system that provides a [...]

We are happy to announce the release of flexiWare 8.0!  This latest version is unified software for both the flexiVent and inExpose systems and flexiWare 8.0 includes features such as: [...]

Reproducibility is more than ever an inevitable topic in research.  Recently, the subject was addressed by Dr. Jason Bates1 specifically in relation to preclinical lung function [...]

The emka & SCIREQ team will be attending the 2017 Society of Toxicology conference in Baltimore. We will be demonstrating our wide range of preclinical instruments for neuro, pulmonary and [...]

Smoking has reached an epidemic proportion worldwide and its effect in terms of health-related issues is huge. While smoking prevention and cessation are key to bringing an end to this epidemic, [...]

Congratulations to Dr. Blackwell’s team at Vanderbilt University who recently published in Nature Communications1! As you may know, chronic obstructive pulmonary disease (COPD) is [...]

Our team of Application Specialist are traveling to sunny San Diego next week to attend the Experimental Biology conference yet again! We will present and demonstrate our solutions for [...]

The American Heart Association’s Scientific Sessions is the leading US cardiovascular conference for basic, translational, clinical and population science. From vascular biology to genetics and [...]